Process elongation of oligodendrocytes is promoted by the kelch-related protein MRP2/KLHL1

被引:22
作者
Jiang, Shuxian [1 ]
Seng, Seyha [1 ]
Avraham, Hava Karsenty [1 ]
Fu, Yigong [1 ]
Avraham, Shalom [1 ]
机构
[1] Harvard Univ, Sch Med, Div Expt Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.M701019200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oligodendrocytes ( OLGs) are generated by progenitor cells that are committed to differentiating into myelin-forming cells of the central nervous system. Rearrangement of the cytoskeleton leading to the extension of cellular processes is essential for the myelination of axons by OLGs. Here, we have characterized a new member of the Kelch-related protein family termed MRP2 ( for Mayven-related protein 2) that is specifically expressed in brain. MRP2/KLHL1 is expressed in oligodendrocyte precursors and mature OLGs, and its expression is up-regulated during OLG differentiation. MRP2/KLHL1 expression was abundant during the specific stages of oligodendrocyte development, as identified by A2B5-, O4-, and O1-specific oligodendrocyte markers. MRP2/KLHL1 was localized in the cytoplasm and along the cell processes. Moreover, a direct endogenous association of MRP2/KLHL1 with actin was observed, which was significantly increased in differentiated OLGs compared with undifferentiated OLGs. Overexpression of MRP2/KLHL1 resulted in a significant increase in the process extension of rat OLGs, whereas MRP2/KLHL1 antisense reduced the process length of primary rat OLGs. Furthermore, murine OLGs isolated from MRP2/KLHL1 transgenic mice showed a significant increase in the process extension of OLGs compared with control wild-type murine OLGs. These studies provide insights into the role of MRP2/KLHL1, through its interaction with actin, in the process elongation of OLGs.
引用
收藏
页码:12319 / 12329
页数:11
相关论文
共 50 条
  • [41] Amelioration of mercury nephrotoxicity after pharmacological manipulation of organic anion transporter 1 (Oat1) and multidrug resistance-associated protein 2 (Mrp2) with furosemide
    Hazelhoff, Maria H.
    Trebucobich, Mara S.
    Stoyanoff, Tania R.
    Chevalier, Alberto A.
    Torres, Adriana M.
    TOXICOLOGY RESEARCH, 2015, 4 (05) : 1324 - 1332
  • [42] Involvement of sphingosine-1P receptor 2 (S1PR2) in taurolithocholate-induced impairment of multidrug resistence-associated protein 2 (Mrp2) in rat
    Andermatten, R.
    Ciriaci, N.
    Razori, M. V.
    Miszczuk, G.
    Barosso, I.
    Pozzi, E. S.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S135 - S135
  • [43] Interactions between human multidrug resistance related protein (MRP2; ABCC2) and excipients commonly used in self-emulsifying drug delivery systems (SEDDS)
    Li, Liang
    Yi, Tao
    Lam, Christopher Wai-kei
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 447 (1-2) : 192 - 198
  • [44] Insulin growth factor 2 mRNA binding protein 1 (IGF2BP1) regulates translation of the multidrug resistance protein 2 (MRP2) by binding to its 5′-untranslated region (5′UTR)
    Vore, Mary
    Zhao, Tianyong
    Zhang, Yanbin
    Yan, Baoxiang
    Thompson, Sunnie R.
    FASEB JOURNAL, 2011, 25
  • [45] Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochrornes P4502B1/2 and 3A1/2 in phenobarbital-treated hepatocytes
    Courtois, A
    Payen, L
    Le Ferrec, E
    Scheffer, GL
    Trinquart, Y
    Guillouzo, A
    Fardel, O
    BIOCHEMICAL PHARMACOLOGY, 2002, 63 (02) : 333 - 341
  • [46] Transport of N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine, a metabolite of trichloroethylene, by mouse multidrug resistance associated protein 2 (Mrp2)
    Tsirulnikov, Kirill
    Abuladze, Natalia
    Koag, Myong-Chul
    Newman, Debra
    Scholz, Karoline
    Bondar, Galyna
    Zhu, Quansheng
    Avliyakulov, Nuraly K.
    Dekant, Wolfgang
    Faull, Kym
    Kurtz, Ira
    Pushkin, Alexander
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2010, 244 (02) : 218 - 225
  • [47] Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical conjugate export pump MRP2 (multidrug resistance protein 2) in Caco-2 cells
    Bock, KW
    Eckle, T
    Ouzzine, M
    Fournel-Gigleux, S
    BIOCHEMICAL PHARMACOLOGY, 2000, 59 (05) : 467 - 470
  • [48] Basal expression of the rat, but not of the human, multidrug resistance protein 2 (MRP2) gene is mediated by CBF/NF-Y and Sp1 promoter-binding sites
    Kauffmann, HM
    Vorderstemann, B
    Schrenk, D
    TOXICOLOGY, 2001, 167 (01) : 25 - 35
  • [49] The trypanocidal benznidazole promotes adaptive response to oxidative injury: Involvement of the nuclear factor-erythroid 2-related factor-2 (Nrf2) and multidrug resistance associated protein 2 (MRP2)
    Pablo Rigalli, Juan
    Gabriela Perdomo, Virginia
    Ciriaci, Nadia
    Antonio Frances, Daniel Eleazar
    Teresa Ronco, Maria
    Bataille, Amy Michele
    Ines Ghanem, Carolina
    Laura Ruiz, Maria
    Manautou, Jose Enrique
    Alicia Catania, Viviana
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2016, 304 : 90 - 98
  • [50] Effect of JBP485 on obstructive jaundice is related to regulation of renal Oat1, Oat3 and Mrp2 expression in ANIT-treated rats
    Liu, Tao
    Guo, Xinjin
    Meng, Qiang
    Wang, Changyuan
    Liu, Qi
    Sun, Huijun
    Ma, Xiaochi
    Kaku, Taiichi
    Liu, Kexin
    PEPTIDES, 2012, 36 (01) : 78 - 85